News Briefs

  4/20/2014, Nissan 20, 5774

Teva Setback: Competitors Can Sell Copaxone, Court Says

A U.S. Supreme Court Justice on Friday rejected a petition by Israeli pharmaceutical maker Teva to prevent competitors from producing generic versions of multiple sclerosis drug Copaxone while hearings go on to extend the patent. The rejection of Teva's request means that competitors, including Mylan, Momenta Pharmaceuticals, and Novartis AG’s Sandoz could start selling generic versions of the drug as soon as next month.